512101 — Triochem Products Balance Sheet
0.000.00%
HealthcareMicro Cap
Annual balance sheet for Triochem Products, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.39 | 82 | 118 | 9.85 | 11.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 124 | 17.2 | 0.68 | 0.76 | 0 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 154 | 110 | 120 | 12.8 | 27.3 |
Net Property, Plant And Equipment | 10.1 | 8.96 | 8 | 6.99 | 6.12 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 166 | 121 | 133 | 118 | 149 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 43.5 | 3.9 | 2.13 | 2.38 | 2.66 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 44.4 | 3.9 | 2.83 | 2.38 | 2.66 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 122 | 117 | 130 | 116 | 146 |
Total Liabilities & Shareholders' Equity | 166 | 121 | 133 | 118 | 149 |
Total Common Shares Outstanding |